01/28/2026
Virginia Kowalsky, an emergency-room nurse from Blackwell, Oklahoma, was on her path to recovery after back surgery when unexpected spotting led to a diagnosis of aggressive uterine cancer. She underwent a hysterectomy followed by chemotherapy, persevering through treatment while continuing to work. After finishing chemotherapy, she was relieved to learn she was in remission. But six months later, mouth sores and low blood platelets revealed something even more serious: therapy-related acute myeloid leukemia (t-AML), a rare blood cancer caused by her previous treatment.
Virginia was referred to hematologist-oncologist Dr. Taha Al-Juhaishi at OU Health Stephenson Cancer Center to begin a stem-cell transplant in November of 2023. The national marrow registry identified a perfect match more than a thousand miles away in northern Alabama. Twelve years after joining the registry on a whim, Dylon Lange didn’t hesitate when called to donate. Despite grueling injections, travel chaos, and a five-hour procedure, he delivered the stem cells that gave Virginia a second chance at life — and says he’d do it again without question. On May 7, 2024, she received the life-saving transplant that allowed her body to rebuild with healthy donor cells.
Today, Virginia is in full remission with 100 percent donor chimerism. While she is adjusting to life without 12-hour ER shifts, she is deeply grateful for her care team, Dr. Al-Juhaishi’s compassion, and Dylon’s selfless act.
Stephenson Cancer Center, Oklahoma’s only NCI-Designated Cancer Center, provides advanced cellular therapy so patients can receive world-class care close to home. Virginia’s story is a powerful reminder of hope, resilience, and the impact of medical innovation.